Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
7,113 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04775485 | A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors(FIREFLY-1) | recruiting | Phase 2 | 141 | Day One Biopharmaceuticals, Inc.INDUSTRY | 11 | Apr 10, 2025 | clinicaltrials |
| NCT05588648 | Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma | recruiting | Phase 1 / Phase 2 | 48 | MedPacto, Inc.INDUSTRY | 2 |
| Apr 10, 2025 |
| clinicaltrials |
| NCT06064695 | Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis | recruiting | N/A | 16 | University of Missouri-ColumbiaOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06258304 | A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies | recruiting | Phase 1 | 60 | GigaGen, Inc.INDUSTRY | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06705075 | Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE | recruiting | Phase 2 | 80 | Thomas Jefferson UniversityOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06096974 | Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS | recruiting | Phase 1 | 60 | Shanghai YingLi Pharmaceutical Co. Ltd.INDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06710379 | A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors | recruiting | Phase 1 | 68 | Adcentrx TherapeuticsINDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT05013255 | Pioglitazone Therapy Targeting Fatigue in Breast Cancer | recruiting | Phase 2 | 30 | West Virginia UniversityOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT05846880 | VitD3 Supplementation in Patients With Multiple Myeloma | recruiting | Early Phase 1 | 100 | Amany Keruakous, MD, MS.OTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06006806 | Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy | recruiting | N/A | 100 | Covenant Health Cancer CenterOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06183268 | Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy | recruiting | N/A | 100 | Covenant Health Cancer CenterOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT05484973 | Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss | recruiting | N/A | 99 | Cooler Heads Care Inc.OTHER_GOV | 1 | Apr 6, 2025 | clinicaltrials |
| NCT03290534 | Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® | recruiting | Phase 2 | 40 | CivaTech OncologyINDUSTRY | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06190730 | REmote Symptom COllection to improVE postopeRative Care(RECOVER) | recruiting | N/A | 281 | Medstar Health Research InstituteOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06493552 | Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors | recruiting | Phase 2 / Phase 3 | 700 | Vasgene Therapeutics, IncINDUSTRY | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06082947 | αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)(TB19DHCT) | recruiting | N/A | 50 | Nationwide Children's HospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06872723 | CPRIT: Patient Adherence to Lung Cancer Screening | recruiting | — | 340 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT03260842 | Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer | recruiting | — | 500 | Stanford UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT03457415 | Collection of Sputum and Labeling for Lung Cancer | recruiting | — | 500 | bioAffinity Technologies Inc.INDUSTRY | 1 | Apr 1, 2025 | clinicaltrials |
| NCT05269316 | Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 61 | Impact Therapeutics, Inc.INDUSTRY | 4 | Apr 1, 2025 | clinicaltrials |
| NCT05460507 | Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment | recruiting | Phase 1 | 40 | Plus TherapeuticsINDUSTRY | 1 | Mar 30, 2025 | clinicaltrials |
| NCT05784688 | Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 140 | TiumBio Co., Ltd.INDUSTRY | 2 | Mar 30, 2025 | clinicaltrials |
| NCT04506008 | Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas | recruiting | Phase 2 | 40 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT04570553 | Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers | recruiting | N/A | 350 | WellSpan HealthOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06693323 | Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC | recruiting | Phase 2 | 34 | University of California, IrvineOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT01906385 | Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) | recruiting | Phase 1 / Phase 2 | 55 | Plus TherapeuticsINDUSTRY | 1 | Mar 26, 2025 | clinicaltrials |
| NCT05337631 | Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy(SENIOR) | recruiting | — | 1,500 | University Hospital FreiburgOTHER | 5 | Mar 25, 2025 | clinicaltrials |
| NCT05776524 | Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer | recruiting | Phase 2 | 46 | THERABIONIC INC.OTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06338475 | A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer | recruiting | N/A | 100 | University of California, IrvineOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT03671044 | A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients | recruiting | Phase 3 | 657 | Jina Pharmaceuticals Inc.INDUSTRY | 2 | Mar 21, 2025 | clinicaltrials |
| NCT06659458 | Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients(EGFR Lung Canc) | recruiting | — | 20 | Our Lady of the Lake HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05728957 | Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors(BIOPSy) | recruiting | — | 100 | Loyola UniversityOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06717243 | Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)(STRATUS) | recruiting | — | 111 | Oncology Center of Biochemical Education And ResearchOTHER | 2 | Mar 19, 2025 | clinicaltrials |
| NCT05819996 | Addressing Tetrachloroethylene Exposure in an Impacted Community | recruiting | N/A | 510 | Purdue UniversityOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT05833360 | Prospective Study of oncRNA Stratification of Cancer by Size and Stage | recruiting | — | 2,400 | Exai Bio Inc.INDUSTRY | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06473103 | Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy | recruiting | N/A | 52 | University of RochesterOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06876831 | Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital. | recruiting | N/A | 150 | Physician Affiliate Group of New YorkOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT04510129 | A Multicenter Cancer Biospecimen Collection Study | recruiting | — | 1,650 | Cofactor Genomics, Inc.INDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06495190 | Cognition, Flavonoids, Exercise, Gut Microbiome | recruiting | N/A | 240 | Appalachian State UniversityOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06707610 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors | recruiting | Phase 1 | 234 | Shanghai Allink Biotherapeutics Co., Ltd.INDUSTRY | 2 | Mar 12, 2025 | clinicaltrials |
| NCT04606030 | LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) | recruiting | N/A | 60 | Fibralign CorporationINDUSTRY | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06488365 | In Vivo Liquid Biopsy of Melanoma (Cytophone)(Cytophone) | recruiting | N/A | 180 | CytoastraINDUSTRY | 1 | Mar 11, 2025 | clinicaltrials |
| NCT05190471 | A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML) | recruiting | Phase 1 | 48 | Bio-Path Holdings, Inc.INDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06613217 | Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia | recruiting | Phase 1 | 35 | Pacylex PharmaceuticalsINDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06866483 | Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment | recruiting | — | 1,000 | ZS AssociatesINDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT02781883 | Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML | recruiting | Phase 2 | 108 | Bio-Path Holdings, Inc.INDUSTRY | 1 | Mar 7, 2025 | clinicaltrials |
| NCT04196257 | BP1001-A in Patients With Advanced or Recurrent Solid Tumors | recruiting | Phase 1 | 50 | Bio-Path Holdings, Inc.INDUSTRY | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06069570 | Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases | recruiting | Phase 1 | 48 | Kiromic BioPharma Inc.INDUSTRY | 1 | Mar 5, 2025 | clinicaltrials |
| NCT05487170 | A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) | recruiting | Phase 1 / Phase 2 | 32 | Ranok Therapeutics (Hangzhou) Co., Ltd.INDUSTRY | 2 | Mar 4, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials